C-RAD AB: Catalyst™ systems to China
1/21/2013 3:00 AM EST
C-Rad AB
Company Announcement
C-RAD AB: Catalyst™ systems to China
A first order of C-RAD Catalyst™ systems to China
C-RAD AB with its three fully owned subsidiaries in Sweden and three
international sales companies are all active in the field of radiation therapy.
C-RAD has received a first order of two Catalyst systems to the Chinese market.
The Catalyst™ is a next-generation high performance tracking system based on
optical surface scanning and augmented reality through re-projection. Advanced
and highly optimized algorithms for non-rigid registration and deformable
models enable clinicians to perform a real-time assessment of patient
positioning errors before and during treatment delivery. Interfaces to major
vendors ensure a completely integrated workflow.
C-RAD is in China selling both direct and via distributors to the radiation
therapy clinics. The C-RAD sales office in Shanghai was founded in July 2012.
Results of the improved presence on the market can already be seen. Technical
support can locally be offered to distributors and end customers.
Erik Hedlund, CEO, C-RAD AB:
”We are happy to announce the first orders of the Catalyst system to the
Chinese market. So far altogether 8 Sentinel and Catalyst systems have been
ordered by Chinese customers. As soon as SFDA approval of the two systems will
be in place, sales will increase. Approval of the Sentinel is expected to be in
place spring 2013.”
Markus Braun, Sales manager, C-RAD WOFE:
“C-RAD and its subsidiary in China is further expanding the activities for
Sentinel and Catalyst systems on the Chinese market. We have from our newly
appointed distributor received two orders of the Catalyst system.
The Chinese market will continue to grow in 2013. The radiation therapy clinics
are showing a positive attitude to the C-RAD products. C-RAD will conduct
further measures in expanding the market presence generating more value by
focused marketing and sales activities and further collaborations that will lay
down the future success in the Chinese market.”